Differences in immune functions between human T-lymphotropic virus type I carriers and patients with adult T-cell leukemia/lymphoma

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages 325-332

  Funai, Noriko ^a   Shimamoto, Yoshinori ^a   Yoshida, Shin Ichi ^b   Nagai, Yoshinori ^a   Nakazato, Sachie ^a   Kohashi, Osamu ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; RECOMBINANT INTERLEUKIN 10; TUBERCULIN; TUMOR NECROSIS FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULINS; LEGIONELLA PNEUMOPHILA; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES; TUBERCULIN TEST;

EID: 0029796940     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0131     Document Type: Article

References (40)

1. Poiesz, B. J., Runsetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C., Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA 77, 7415-7419, 1980.
2. Yoshida, M., Seiki, M., Yamaguchi, K., and Takatsuki, K., Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests a causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA 81, 2534-2537, 1984.
3. Shimamoto, Y., Suga, K., Shibata, K., Matsuzaki, M., Yano, H., and Yamaguchi, M., Clinical importance of extraordinary integration patterns of human T-cell lymphotrophic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood 84, 853-858, 1994.
4. Shaw, G. M., Broder, S., Essex, M., and Gallo, R. C., Human T-cell leukemia virus: Its discovery and role in leukemogenesis and immunosuppression. Adv. Intern. Med. 30, 1-27, 1984.
5. Blattner, W., Kalyanaraman, V. S., Robert-Guroff, M., Lister, T. A., Galton, D. A. G., Sarin, P. S., Crawford, M. H., Catovsky, D., Greaves, M., and Gallo, R. C., The human type-C retrovirus, HTLV, in blacks from the Caribbean region and relationship to adult T-cell leukemia/lymphoma. Int. J. Cancer 20, 257-264, 1982.
6. The T- and B-cell Malignancy Study Group, Statistical analysis of immunologic, clinical and histopathologic data on lymphoid malignancies in Japan. Jpn. J. Clin. Oncol. 11, 15 -38, 1981.
7. Ono, K., Shimamoto, Y., Suga, K., Tokioka, T., Sueoka, E., Matsuzaki, M., Sano, M., Yamaguchi, M., Suzuki, H., Sato, H., and Shimoyama, M., Cancer superimposed on adult T-cell leukemia. Cancer 64, 635-640, 1989.
8. Eizuru, Y., Tamura, K., Minamishima, Y., Ogata, K., Tada, S., Inoue, S., Takeshita, M., and Kikuchi, M., Cytomegalovirus infections in adult T-cell leukemia patients. J. Med. Virol. 23, 123-133, 1987.
9. O'Doherty, M. J., Van der Pette, J. E., Nunan, T. O., and Croft, D. N., Recurrent Stronglyoides stercoralis infection in a patient with T-cell lymphoma-leukemia. Lancet I, 858, 1984.
10. Nakada, K., Yamaguchi, K., Furugen, S., Nakasone, T., Nakasone, K., Oshiro, Y., Kohakura, M., Hinuma, Y., Seiki, M., Yoshida, M., Matutes, E., Catovsky, D., Ishii, T., and Takatsuki, K., Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int. J. Cancer 40, 145-148, 1987.
11. Funai, N., Shimamoto, Y., Tokunaga, O., Sugihara, W., and Yamaguchi, M., Ten-year survey of incidence of infection as a cause of death in hematologic malignancies: Study of 90 autopsied cases. Acta Haematol. 93, 25-30, 1995.
12. Nakada, K., Kohakura, M., Komoda, H., and Hinuma, Y., High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet I, 858, 1984.
13. Asou, N., Kumagai, T., Uekihara, S., Ishii, M., Sato, M., Sakai, K., Nishimura, H., Yamaguchi, K., and Takatsuki, K., HTLV-I seroprevalence in patients with malignancy. Cancer 58, 903-907, 1986.
14. Tachibana, N., Okayama, A., Ishizaki, J., Yokota, T., Shishime, E., Murai, K., Shioiri, S., Tsuda, K., Essex, M., and Mueller, N., Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int. J. Cancer 42, 829-831, 1988.
15. Taguchi, H., Kobayashi, M., and Miyoshi, I., Immunosuppression by HTLV-I infection. Lancet 337, 308, 1991.
16. Eisenstein, T. K., and Friedman, H., Immunity to Legionella. In "Legionellosis" (S. M. Katz, Ed.), pp. 159-169, CRC Press, Boca Raton, FL, 1985.
17. Horwitz, M. A., and Silverstein, S. C., Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J. Exp. Med. 153, 386-397, 1981.
18. Watanabe, M., Shimamoto, Y., Yoshida, S., Suga, K., Mizuguchi, Y., Kohashi, O., and Yamaguchi, M., Intracellular multiplication of Legionella pneumophila in HL-60 cells differentiated by 1,25dihydroxyvitamin D3 and the effect of Interferon γ. J. Leukocyte Biol. 54, 40-46, 1993.
19. Matsuzaki, M., Shimamoto, Y., Watanabe, M., Kukita, A., Yoshida, S., and Tadano, J., Intracellular multiplication of Legionella pneumophila in HL-60 cells functionally differentiated in response to 22-oxacalcitriol. J. Leukocyte Biol. 57, 574-580, 1995.
20. Tokudome, S., Tokunaga, O., Shimamoto, Y., Miyamoto, Y., Sumida, I., Kikuchi, M., Takeshita, M., Ikeda, T., Fujiwara, K., Yoshihara, M., Yanagawa, T., and Nishizumi, M., Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res. 49, 226-268, 1989.
21. Shimamoto, Y., Yamaguchi, M., Miyamoto, Y., Yamaguchi, J., Kuribayashi, N., Sato, H., Nishimura, J., Nawata, H., Kozuru, M., and Shimoyama, M., The differences between lymphoma and leukemia type of adult T-cell leukemia. Leukemia Lymphoma 1, 101-112, 1990.
22. Shimamoto, Y., Kikuchi, M., Funai, N., Suga, K., Matsuzaki, M., and Yamaguchi, M., Spontaneous regression in adult T-cell leukemia/lymphoma. Cancer 72, 735-740, 1993.
23. Shimoyama, M., and members of the Lymphoma Study Group (1984-1987), Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br. J. Haematol. 79, 428-437, 1991.
24. Shimamoto, Y., and Yamaguchi, M., HTLV-I induced extranodal lymphomas. Leukemia Lymphoma 7, 37-45, 1992.
25. Shimamoto, Y., Ono, K., Sano, M., Matsuzaki, M., Suga, K., Sueoka, E., Tokioka, T., Yamaguchi, M., Suzuki, H., Sato, H., and Shimoyama, M., Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia. Cancer 63, 289-294, 1989.
26. Mayer, M. M., Complement and complement fixation. In "Experimental Immunochemistry" (E. A. Kabat and M. M. Mayer, Eds.), pp. 133-240, Thomas, Springfield, IL, 1961.
27. Vindelov, L., Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch. B. Cell Path. 24, 227-242, 1977.
28. Bass, J. B., Farer, L. S., Hopewell, P. C., Jacobs, R. F., and Snider, D. E., Diagnostic standards and classification of tuberculosis. Am. Rev. Respir. Dis. 142, 725-735, 1990.
29. Tokioka, T., Shimamoto, Y., Motoyoshi, K., and Yamaguchi, M., Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukemia/lymphoma. Haematologia 26, 1-9, 1994.
30. Kobayashi, M., Miyoshi, I., Sonobe, H., Taguchi, H., and Kubonishi, I., Association of Pneumocystis carinii pneumonia and scabies. J. Am. Med. Assoc. 248, 1973, 1982.
31. Bunn, P. A., Schehter, G. P., Jaffe, E. J., Blayney, D., Young, R. C., Matthews, M. J., Blattner, W., Broder, S., Robert-Guroff, M., and Gallo, R. C., Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 309, 257-264, 1983.
32. Funai, N., Shimamoto, Y., Matsuzaki, M., Watanabe, M., Tokioka, T., Sueoka, E., Suga, K., Ono, K., Sano, M., and Yamaguchi, M., Hyperkalemia with renal tubular dysfunction by sulfamethoxazole-trimethoprin for Pneumocystis carinii pneumonia in patients with lymphoid malignancy. Hematologia 25, 137-141, 1993.
33. Graziosi, C., Pantaleo, G., Gantt, K. R., Fortin, J.-P., Demarest, J. F., Cohen, O. J., Sekaldy, R. P., and Fauci, A. S., Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265, 248-252, 1994.
34. Helbert, M., Robinson, D., Buchanan, D., Hellyer, T., McCarthy, M., Brown, I., Pinching, A. J., and Mitchell, D. M., Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax 45, 45-48, 1990.
35. Shirakawa, F., Tanaka, Y., Oda, S., Chiba, S., Suzuki, H., Eto, S., and Yamashita, U., Immunosuppressive factors from adult T-cell leukemia cells. Cancer Res. 46, 4458-4462, 1986.
36. Yamada, Y., Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 61, 192-199, 1983.
37. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., and Tara, M., HTLV-I associated myelopathy: A new clinical entity. Lancet I, 1031-1032, 1986.
38. Gassain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A., and de-The, G., Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410, 1985.
39. Itoyama, Y., Minato, S., Kira, J., Goto, I., Sato, H., Okochi, K., and Yamamoto, N., Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38, 1302-1307, 1988.
40. Matsumoto, T., Miike, T., Mizoguchi, K., Yamaguchi, K., Takatsuki, K., Hosoda, M., Kawabe, T., and Yodoi, J., Decreased serum levels of IgE and IgE-binding factors in individuals infected with HTLV-I. Clin. Exp. Immunol. 81, 207-211, 1990.